연구성과로 돌아가기
2023 연구성과별 연구자 정보 (832 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Park, Jung Ho | Park, JH | 6 | Sungkyunkwan Univ, Coll Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea | hwoonymd@gmail.com; | |||||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Kim, Gwang Ha | Kim, GH | 7 | Pusan Natl Univ, Dept Internal Med, Biomed Res Inst, Pusan Natl Univ Hosp,Sch Med, Pusan, South Korea | ABF-3932-2021 | Kim, Gwang Ha | hwoonymd@gmail.com; | |||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Shin, Sung Kwan | Shin, SK | 8 | Yonsei Univ, Coll Med, Dept Internal Med, Div Gastroenterol,Inst Gastroenterol, Seoul, South Korea | 0000-0001-5466-1400 | Shin, Sung Kwan | hwoonymd@gmail.com; | |||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Hong, Su Jin | Hong, SJ | 9 | SoonChunHyang Univ, Digest Dis Ctr & Res Inst, Dept Internal Med, Coll Med, Bucheon, South Korea | hwoonymd@gmail.com; | |||||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Lee, Kwang Jae | Lee, KJ | 10 | Ajou Univ, Sch Med, Dept Gastroenterol, Suwon, South Korea | hwoonymd@gmail.com; | |||||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Park, Moo In | Park, MI | 11 | Kosin Univ, Coll Med, Dept Internal Med, Busan, South Korea | hwoonymd@gmail.com; | |||||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Jung, Hye-Kyung | Jung, HK | 12 | Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea | hwoonymd@gmail.com; | |||||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Kim, Hyun-Soo | Kim, HS | 13 | Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea | hwoonymd@gmail.com; | |||||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Sung, Jae Kyu | Sung, JK | 14 | Chungnam Natl Univ, Coll Med, Dept Internal Med, Daejeon, South Korea | hwoonymd@gmail.com; | |||||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Jeon, Seong Woo | Jeon, SW | 15 | Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea | AAU-4618-2020 | Jeon, Seongwoo | hwoonymd@gmail.com; | |||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Choi, Suck Chei | Choi, SC | 16 | Wonkwang Univ Hosp, Digest Dis Res Inst, Dept Gastroenterol, Iksan, South Korea | hwoonymd@gmail.com; | |||||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Moon, Jeong Seop | Moon, JS | 17 | Inje Univ, Coll Med, Dept Internal Med, Seoul, South Korea | hwoonymd@gmail.com; | |||||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Kim, Nayoung | Kim, N | 18 | Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea | AAR-4892-2020 | Kim, Hong | hwoonymd@gmail.com; | |||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Park, Jong-Jae | Park, JJ | 19 | Korea Univ, Coll Med, Dept Internal Med, Div Gastroenterol,Guro Hosp, Seoul, South Korea | hwoonymd@gmail.com; | |||||
| Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | Hong, Sung Hee | Hong, SH | 20 | Hanmi Pharmaceut Co Ltd, Seoul, South Korea | hwoonymd@gmail.com; |
페이지 이동: